BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ROS1, ROS, 6098, ENSG00000047936, P08922, MCF3, RP1-179P9_1
72920 results:

  • 1. FAT1 inhibits the proliferation of DLBCL cells via increasing the m
    Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N
    Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure.
    Yan M; Gao J; Lan M; Wang Q; Cao Y; Zheng Y; Yang Y; Li W; Yu X; Huang X; Dou L; Liu B; Liu J; Cheng H; Ouyang K; Xu K; Sun S; Liu J; Tang W; Zhang X; Man Y; Sun L; Cai J; He Q; Tang F; Li J; Shen T
    Signal Transduct Target Ther; 2024 May; 9(1):127. PubMed ID: 38782919
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
    Li X; Wu D; Tang J; Wu Y
    J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.
    Salem AH; Menon RM
    Clin Transl Sci; 2024 May; 17(5):e13807. PubMed ID: 38778732
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
    Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
    BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL.
    Wang X; Deng Y; He G; Lai S; Li Y; Zhang S; He Y; Han Y; Zhang L; Su Y; Liu F; Yi H
    Hematology; 2024 Dec; 29(1):2356300. PubMed ID: 38776229
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
    Morsy MHA; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
    Blood; 2024 Jan; 143(19):1953-1964. PubMed ID: 38774451
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length.
    Carlund O; Thörn E; Osterman P; Fors M; Dernstedt A; Forsell MNE; Erlanson M; Landfors M; Degerman S; Hultdin M
    Clin Epigenetics; 2024 May; 16(1):68. PubMed ID: 38773655
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.
    Durand M; Cabaud Gibouin V; Duplomb L; Salmi L; Caillot M; Sola B; Camus V; Jardin F; Garrido C; Jego G
    J Exp Clin Cancer Res; 2024 May; 43(1):148. PubMed ID: 38773631
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.
    Xu T; Wu L; Ye H; Luo S; Wang J
    Diagn Pathol; 2024 May; 19(1):69. PubMed ID: 38773600
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
    Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
    Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Strategies for increasing accrual in cancer clinical trials: What is the evidence?
    Michaels M; Weiss ES; Sae-Hau M; Illei D; Lilly B; Szumita L; Connell B; Lee M; Cooks E; McPheeters M
    Cancer Med; 2024 May; 13(10):e7298. PubMed ID: 38770644
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Proteomic characterization and cytotoxic potential of proteins from Cuscuta (Cuscuta epithymum (L.) crude herbal product against MCF-7 human breast cancer cell line.
    Akhtar U; Khurshid Y; El-Aarag B; Syed B; Khan IA; Parang K; Ahmed A
    BMC Complement Med Ther; 2024 May; 24(1):195. PubMed ID: 38769554
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
    Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
    Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Application and prognostic relevance of CD34 detection in immunophenotyping of pediatric acute B lymphoblastic leukemia.
    Zha W; Yuan Y; Yang T; Zhu LJ; Kong WY; Zhuo JJ
    Eur Rev Med Pharmacol Sci; 2024 May; 28(9):3384-3390. PubMed ID: 38766795
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
    Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
    J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Milia en plaque on the shoulder as an early manifestations of mycosis fungoides.
    Rodrigues FT; Cabral GCCC; Alvim PFMF; Junior DDAD; Ciganha LS; Leal JM; Scotelaro MFG; Gripp AC
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762866
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    GBD 2021 Risk Factors Collaborators
    Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
    Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
    Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3646.